Partical Clinical Hold on Cell Therapeutics' (CTIC) Tosedostat Removed by FDA
Tweet Send to a Friend
Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC) announced that it has received notification from the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE